Abstract

The purpose of this contract, entitled Development of Anthim - a Monoclonal Antibody for the Treatment of Inhalational Anthrax, is to support advanced product development activities for Anthim , a therapeutic for post-exposure treatment of inhalation anthrax.

  Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research and Development Contracts (N01)
Project #
272200700035C-2-0-1
Application #
7695828
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2008
Total Cost
$883,563
Indirect Cost

  Institution

Name
Elusys Therapeutics, Inc.
Department
Type
DUNS #
083819511
City
Pine Brook
State
NJ
Country
United States
Zip Code
07058